3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
CNS
1
Conditions
Neuroblastoma
10
Melanoma
8
Neoplasm Metastasis
6
Breast Neoplasms
6
Ganglioneuroblastoma
5
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Multiple Myeloma
4
Lymphoma
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Myelodysplastic Syndromes
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Acute
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Glioblastoma
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Uveal Melanoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Oligodendroglioma
2
Neoplasms
2
Medulloblastoma
2
Lymphoma, Follicular
2
Leukemia
2
Gliosarcoma
2
Glioma
2
Carcinoma, Intraductal, Noninfiltrating
2
Astrocytoma
2
Interventions
pembrolizumab
180
Gemcitabine
168
Paclitaxel
150
Carboplatin
134
Bevacizumab
126
Cisplatin
113
Docetaxel
112
Cyclophosphamide
109
Exercise
97
Nivolumab
93
Fluorouracil
88
Capecitabine
85
Dexamethasone
81
Irinotecan
74
Radiotherapy
68
Oxaliplatin
68
Pemetrexed
66
Standard of Care
64
Leucovorin
63
Cetuximab
59
Sorafenib
53
Erlotinib Hydrochloride
53
Drug Therapy
53
Blood Specimen Collection
51
Doxorubicin
50
atezolizumab
48
trametinib
47
Ipilimumab
47
Albumin-Bound Paclitaxel
44
130-nm albumin-bound paclitaxel
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms
×
Colony-Stimulating Factors
×
Clear all
NCT05421897
2026-01-29
RAPID
Children's Hospital Los Angeles
Phase 1
Active not recruiting
11 enrolled
NCT05344209
2023-11-09
LUNGVAC
Vestre Viken Hospital Trust
Phase 2
Recruiting
138 enrolled